CE0913: The Art of Dental Therapeutics: Drugs and Drug Interactions

Mark Donaldson BSc(Pharm), RPh, PharmD, FASHP

DATE:
Friday, October 16, 2009

LOCATION:
Washington State History Museum
Mount Tahoma Auditorium
1911 Pacific Avenue
Tacoma, Washington 98402
(253) 272-3500
(888) 238-4373

TARGET AUDIENCE:
This course is designed for dentists, hygienists, dental assistants and office staff.

REGISTER:
Download Course Application Form
or
Register Online

TIMES:
Registration and Continental Breakfast: 8:00am - 8:30am
Lecture: 8:30am - 4:30pm

TUITION:

Until October 14
$260/Dentist
$165/Staff
$234/Current Dental Alumni Member

After October 14
$270/Dentist
$175/Staff
$244/Current Dental Alumni Member

CREDITS:
7 hours

* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.

Course Description:

Did you know that more than 20% of hospital admissions are due to adverse drug reactions? Although dentists prescribe less than 10% of all available drugs, your patients may be taking many others from the 90% with which you may not be familiar. Since polypharmacy is the norm, especially in the over 65-year old population, this course is essential to every practice setting today.

Do you have patients who are already on one prescription medication before they come to your office? How about four prescription medications? Did you know that the likelihood of a drug interaction in a patient on five medications is greater than 50%? What if you are the prescriber who writes the fifth prescription? With so many new medications, herbal products, over-the-counter drugs, and supplements available on the market, how can you be confident that the prescription you write is compatible with what your patient is currently taking?

This interactive program looks at some of the more common drugs and drug interactions and their management with a particular focus on the dental realm. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant's questions are addressed. After all, when an adverse drug reaction occurs due to a drug interaction, who is more at risk - you or your patient?

This course will also provide updates on analgesic and antibiotic selection and therapy, bisphosphonate-induced osteonecrosis of the jaw (BONJ), pain and anxiety control and more!

Course Objectives - As a result of attending this course, the participant should be able to:

Discuss the principles of pharmacokinetics, pharmacodynamics and pharmacogenomics.
Learn to match the right drug at the right dose to the right patient and the right procedure.
Describe the potential for drug-drug interactions and articulate strategies to avoid or manage them.
Recognize reputable databases and references and how to utilize these tools to evaluate drug therapies and interactions.
Describe the mechanism of action of popular pain medications and understand why some drugs work and some don’t for postoperative dental pain.
Understand the principles of appropriate antibiotic prescribing.
Learn about the most recent research on bisphosphonates and osteonecrosis of the jaw.
Understand the principles of drug metabolism including liver enzyme induction and inhibition.
Describe the medications used for safe and effective minimal and moderate sedation using oral and inhalational techniques.

Instructor:

MARK DONALDSON received his BSc(Pharm.) from the University of British Columbia and his Doctorate in Clinical Pharmacy from the University of Washington. He has further completed a residency at Canada’s largest tertiary care facility, Vancouver General Hospital, and is the current Director of Pharmaceutical Services at the Kalispell Regional Medical Center.

Dr. Donaldson is a faculty member and Full Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Assistant Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He is also a continuing education speaker for the University of Washington, Washington State University, Oregon Health Sciences University, the University of Pennsylvania, and the University of British Columbia.

Dr. Donaldson has a special interest in dental pharmacology and has lectured internationally on a number of related topics for both dental and medical practitioners. He has been a primary author and investigator for the National Institutes of Health (N.I.H.) Consensus Development Committee to define the guidelines for enteral sedation in the United States, as well as an invited expert to compose a whitepaper on Enteral Conscious Sedation for the Academy of General Dentistry (A.G.D.). Dr. Donaldson has a number of published works in the peer-reviewed literature, and has spent three years in Japan focussing on cross-cultural communication and internationalization.

Need a hotel in the area?

University of Washington is an ADA CERP Recognized Provider.

The University of Washington is an ACDE member.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

University of Washington designates this activity for 7 continuing education credits.